Literature DB >> 20028871

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.

Stephen S Myatt1, Jun Wang, Lara J Monteiro, Mark Christian, Ka-Kei Ho, Luca Fusi, Roberto E Dina, Jan J Brosens, Sadaf Ghaem-Maghami, Eric W-F Lam.   

Abstract

Endometrial cancer is the most common malignancy of the lower female reproductive tract. The tumor suppressor FOXO1 is downregulated in endometrial cancer compared with normal endometrium but the underlying mechanisms are not well understood. Using microRNA (miR) target prediction algorithms, we identified several miRs that potentially bind the 3'-untranslated region of FOXO1 transcripts. Expression profiling of normal and malignant endometrial samples by quantitative real-time PCR and Northern blot analysis revealed an inverse correlation between the levels of FOXO1 protein and the abundance of several of the in silico-predicted miRs, suggesting that loss of FOXO1 expression in endometrial cancer may be mediated by miRs. To determine the role of candidate miRs, we used the endometrial cancer cell lines HEC-1B and Ishikawa, which express FOXO1 at high and low levels, respectively. Expression of miR-9, miR-27, miR-96, miR-153, miR-182, miR-183, or miR-186, but not miR-29a, miR-128, miR-152, or miR-486 mimetics in HEC-1B cells was sufficient to significantly reduce the abundance of FOXO1. Conversely, FOXO1 expression was efficiently restored in the Ishikawa cell line upon simultaneous inhibition of miR-9, miR-27, miR-96, miR-153, miR-183, and miR-186. Moreover, induction of FOXO1 in Ishikawa cells by miR inhibitors was accompanied by G1 cell cycle arrest and cell death, and was attenuated by the small interfering RNA-mediated downregulation of FOXO1 expression. Our findings identify several miRs overexpressed in endometrial cancer that function in concert to repress FOXO1 expression. Further, aberrant miR expression results in deregulated cell cycle control and impaired apoptotic responses, and thus, may be central to endometrial tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028871      PMCID: PMC2880714          DOI: 10.1158/0008-5472.CAN-09-1891

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

2.  Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.

Authors:  Richard O Burney; Said Talbi; Amy E Hamilton; Kim Chi Vo; Mette Nyegaard; Camran R Nezhat; Bruce A Lessey; Linda C Giudice
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

Review 3.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

4.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

5.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; J P Baak; J A Lees; L P Weng; C Eng
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

6.  Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium.

Authors:  Soraya Labied; Takeshi Kajihara; Patricia A Madureira; Luca Fusi; Marius C Jones; Jenny M Higham; Rana Varshochi; Julia M Francis; Georgia Zoumpoulidou; Abdelkader Essafi; Silvia Fernandez de Mattos; Eric W-F Lam; Jan J Brosens
Journal:  Mol Endocrinol       Date:  2005-08-25

7.  Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.

Authors:  Anna V Hoekstra; Erin C Ward; Jennifer L Hardt; John R Lurain; Diljeet K Singh; Barbara M Buttin; Julian C Schink; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-01-29       Impact factor: 5.482

8.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

Review 9.  Management of advanced-stage and recurrent endometrial cancer.

Authors:  Mandira Ray; Gini Fleming
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

10.  FOXO transcription factors: key regulators of cell fate.

Authors:  E W-F Lam; R E Francis; M Petkovic
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

View more
  159 in total

1.  Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

Authors:  Xunqin Yin; Mary Ellen Pavone; Zhenxiao Lu; JianJun Wei; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.

Authors:  Shyamal Dilhan Weeraratne; Vladimir Amani; Natalia Teider; Jessica Pierre-Francois; Dominic Winter; Min Jeong Kye; Soma Sengupta; Tenley Archer; Marc Remke; Alfa H C Bai; Peter Warren; Stefan M Pfister; Judith A J Steen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2012-03-10       Impact factor: 17.088

3.  MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Cell Mol Life Sci       Date:  2010-09-19       Impact factor: 9.261

4.  Differential expression of microRNAs during allograft rejection.

Authors:  L Wei; M Wang; X Qu; A Mah; X Xiong; A G C Harris; L K Phillips; O M Martinez; S M Krams
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

Review 5.  Non-coding RNAs in Uterine Development, Function and Disease.

Authors:  Warren B Nothnick
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 6.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

7.  Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.

Authors:  F Xu; H Zhang; Y Su; J Kong; H Yu; B Qian
Journal:  Clin Transl Oncol       Date:  2014-05-08       Impact factor: 3.405

8.  Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p.

Authors:  Carlos Marino Cabral Calvano Filho; Daniele Carvalho Calvano-Mendes; Kátia Cândido Carvalho; Gustavo Arantes Maciel; Marcos Desidério Ricci; Ana Paula Torres; José Roberto Filassi; Edmund Chada Baracat
Journal:  Tumour Biol       Date:  2014-05-09

9.  MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.

Authors:  Yuwen Song; Luyan Mu; Xuezhe Han; Qingla Li; Baijing Dong; Hulun Li; Xiaoqian Liu
Journal:  J Neurooncol       Date:  2013-09-17       Impact factor: 4.130

10.  MicroRNA-182-5p targets a network of genes involved in DNA repair.

Authors:  Keerthana Krishnan; Anita L Steptoe; Hilary C Martin; Shivangi Wani; Katia Nones; Nic Waddell; Mythily Mariasegaram; Peter T Simpson; Sunil R Lakhani; Brian Gabrielli; Alexander Vlassov; Nicole Cloonan; Sean M Grimmond
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.